Startups

Memodio
Potsdam, Germany
memodio GmbH is a Potsdam digital-health company developing a multimodal mobile therapy for people with mild cognitive impairment and mild dementia. Founded inDecember2021 as a spin-off of the University of Potsdam and Hasso Plattner Institute, it combines cognitive exercises, physical activity, nutritional guidance, risk-factor education and support for everyday routines and social participation. The founders are physicians Doron Benjamin Stein and Felix Bicu and software engineer Paul Zimmermann. Its registered identity is Potsdam HRB36139P, VATDE351312294, with offices atPotsdamTransfer, August-Bebel-Straße89. Its native instructions identify the app as an MDR ClassI CE-marked medical device. The statutory-insurer association’s official2025 DiGA report records admission onDecember27,2025 with status Erprobung, meaning provisional listing; the company’s current pages describe prescription and German statutory-health-insurance reimbursement. A live BfArM record requires JavaScript and its full current entry was not retrievable during this audit, so permanent listing is not asserted. A registered exploratory MEMODIO_APP@CARE trial studied mild cognitive impairment and mild dementia; published2025 interim findings concern cognition in a subset and do not establish a dementia cure or universal clinical benefit. Its direct neuroscience relevance lies in cognitive-health software and digital therapy; an independent general-purpose AI platform is not claimed. Primary funding includes a EUR400,000 first angel round announcedFebruary2,2023 and a Companisto member-network campaign recorded as endedMay6,2026 with EUR1,152,465. The company also publicly discloses research and innovation grant programmes, whose cash totals and settlement dates are not published.
Founded 2021










